Compare FTRE & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTRE | INOD |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | 1993 |
| Metric | FTRE | INOD |
|---|---|---|
| Price | $17.21 | $52.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $12.64 | ★ $91.67 |
| AVG Volume (30 Days) | ★ 1.4M | 931.4K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.46 |
| EPS | N/A | ★ 1.01 |
| Revenue | ★ $2,759,900,000.00 | $238,467,000.00 |
| Revenue This Year | $3.17 | $48.85 |
| Revenue Next Year | $0.11 | $25.93 |
| P/E Ratio | ★ N/A | $52.01 |
| Revenue Growth | 1.88 | ★ 73.57 |
| 52 Week Low | $3.97 | $26.41 |
| 52 Week High | $20.26 | $93.85 |
| Indicator | FTRE | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 70.75 | 42.30 |
| Support Level | $17.11 | $52.11 |
| Resistance Level | $18.04 | $55.18 |
| Average True Range (ATR) | 0.92 | 2.73 |
| MACD | 0.03 | 0.50 |
| Stochastic Oscillator | 75.53 | 43.43 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.